Karen H. Lu, MD, Chair

The University of Texas M.D. Anderson Cancer Center

LuDr. Lu is Professor and Vice Chair of Prevention and Biomarker Research in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center, and also hold the H.E.B. Professorship of Cancer Research. She is Director of the Uterine Cancer Research Program and Principal Investigator of the Uterine Cancer Specialized Program of Research Excellence (SPORE), a large $10 million NIH grant focused on the prevention and treatment of Uterine Cancer.

She completed her gynecologic oncology fellowship at Brigham and Women’s Hospital/ Dana-Farber Cancer Institute. In addition to treating gynecologic cancer patients, she participates in research to apply laboratory-based findings to improving the care of uterine and ovarian cancer patients. She has received support for her research from the National Cancer Institute, the Lynne Cohen Foundation, the American Gynecologic and Obstetric Society, and the Ovarian Cancer Research Fund. Dr. Lu is also an international expert in hereditary gynecologic cancers, and co-directs the Clinical Cancer Genetics Program at MD Anderson.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

The CDC recently announced that fewer than half of American children are given the HPV vaccination.

Research

As of the July 23 deadline, 55 research abstracts were submitted in hopes of receiving one of only 6 grants from the Foundation. This points to a need for more funding so that the Foundation may award grants to every deserving applicant.

Education

The Gynecologic Cancer Global Health Forum will be Saturday, Sept. 6, 2014 in D.C.. For more information on educational events and courses, click here.